Specialty chemicals firm Stepan Q3 profit misses estimates

Stepan

29/10/2025 11:15

Overview

Stepan Q3 revenue rose 8% yr/yr but missed analyst expectations

Adjusted EPS for Q3 missed consensus, affected by higher tax rate and interest expense

Adjusted EBITDA grew 6% yr/yr, driven by Specialty Products performance

Outlook

Stepan expects continued growth in Surfactant business across key strategic end markets

Company anticipates improving Polymer demand with increased market certainty

Stepan remains optimistic about full-year adjusted EBITDA growth and positive free cash flow

Result Drivers

SPECIALTY PRODUCTS GROWTH - Earnings growth in Specialty Products was driven by order timing differences

SURFACTANT SALES INCREASE - Surfactant net sales rose 10% due to higher selling prices and improved product mix

POLYMER VOLUME GROWTH - Polymer sales volume increased 8% due to growth in North American Rigid and Phthalic Anhydride

Key Details

Metric
Beat/Miss
Actual
Consensus Estimate
Q3 Sales
Miss
$590.28 mln
$593.65 mln (2 Analysts)
Q3 Adjusted EPS
Miss
$0.48
$0.61 (2 Analysts)
Q3 EPS
$0.47
Q3 Adjusted Net Income
$10.94 mln
Q3 Net Income
$10.83 mln
Q3 Operating Income
$21.79 mln


Analyst Coverage

The one available analyst rating on the shares is "hold"

The average consensus recommendation for the specialty chemicals peer group is "buy."

The stock recently traded at 13 times the next 12-month earnings vs. a P/E of 15 three months ago

Press Release: ID:nPn5JtjS0a

For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com.

(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)